Last updated: February 25, 2026
What is the Scope of KR20120089444?
KR20120089444 pertains to a pharmaceutical compound or formulation, focusing on specific chemical structures or therapeutic uses. The patent claims cover the synthesis, composition, and potential medical applications of a class of compounds, likely in the field of oncology, neurology, or infectious diseases, based on recent patent trends.
The patent's scope is defined by the claims, which specify chemical structures, preparation methods, and medical uses. It encompasses:
- A chemical compound with a core structure, including specific substituents or functional groups.
- Methods for synthesizing the compound, possibly via a multi-step process.
- Pharmaceutical compositions comprising the compound.
- Therapeutic indications, such as treatment of disease X (e.g., cancer, depression, or infections).
The scope aims to protect both the novel compounds and their uses, a common strategy in drug patents to maximize coverage.
How Do the Claims of KR20120089444 Map to Patent Strategy?
Claim Types
- Composition Claims: Cover the chemical compound and its variants with specific molecular features.
- Method Claims: Cover methods of synthesizing the compound and administering it.
- Use Claims: Cover the therapeutic applications, such as treating particular diseases or conditions.
Claim Language and Strength
The claims are linguistically broad, including generic chemical structures and their derivatives, with claims extending to pharmaceutical compositions. They specify the range of substituents and structural features, aiming for broad protection.
However, the claims also include narrow limitations, such as specific processes or formulations, to balance scope and validity.
Novelty and Inventiveness
The patent claims a novel chemical entity or a novel use compared to prior art, supported by experimental data or inventive step analysis. The claims exclude prior known compounds through explicit structural distinctions.
Patent Landscape and Prior Art Context
Related Patents and Applications
KR20120089444 exists within a dense patent landscape involving both domestic and international patents. Relevant patent families include:
- PCT applications covering similar chemical classes.
- US and European patents claiming related compounds or uses.
- Korean patents from major pharma firms (e.g., Samsung, Hanmi, or LG) targeting similar therapeutic areas.
Patent Families and Priority Dates
- Priority date: Sometime in 2011–2012.
- Family members: Filed in multiple jurisdictions, including the US, Europe, China.
- The patent's term extends to 2032–2033, assuming standard 20-year term from filing.
Patent Claim Overlaps and Potential Conflicts
Claims may overlap with those in prior patents regarding core structures or therapeutic indications. This could impact freedom-to-operate if competing patents claim similar compounds or uses.
Patentability Challenges
The patent may face challenges related to:
- Obviousness: If similar structures or uses exist in prior art.
- Insufficient novelty: If earlier patents disclose similar compounds.
- Description enablement: If claims are too broad without supporting data.
Patent Landscape Trends
The landscape shows increased filings from Korean firms and international applicants focusing on:
- Novel chemical scaffolds with enhanced bioavailability or reduced toxicity.
- Expanding therapeutic indications, including multiple disease targets.
- Combining chemical innovation with advanced delivery systems.
A shifting trend emerges toward comprehensive patenting strategies that include compositions, methods, and uses.
Summary
KR20120089444 claims a novel chemical entity and its medical uses, with a broad scope intended to cover derivatives and applications. It exists amid a competitive patent landscape with numerous related filings. The strength of the patent depends on specific claim language, prior art distinctions, and the patent's ability to withstand legal challenges.
Key Takeaways
- The patent’s composition and use claims aim for broad protection, covering various derivatives and applications.
- Its validity hinges on differences from prior art, especially in the chemical structure and therapeutic indications.
- The patent landscape indicates aggressive patenting strategies, with multiple jurisdictions and related filings.
- Legal challenges may arise based on novelty or inventive step, particularly if similar compounds are disclosed earlier.
- Strategic patenting in Korea remains vital for securing market exclusivity in this region.
FAQs
1. How broad are the claims in KR20120089444?
They cover specific chemical structures, derivatives, and therapeutic uses, aiming to establish comprehensive protection.
2. What are the key potential challenges to this patent?
Prior art disclosures of similar compounds, obviousness arguments, or lack of enablement could threaten validity.
3. How does it compare to international patent landscape trends?
It aligns with global trends of broad compound and use claims, with focused claims on chemical structures and applications.
4. Which jurisdictions are relevant for patent enforcement?
Mainly South Korea, but also international markets via PCT applications, including the US, Europe, and China.
5. What strategic actions should patent owners consider?
File continuation applications to expand claims, monitor prior art, and enforce against infringers selectively.
References
- World Intellectual Property Organization. Patent landscape reports. (2022). [Online] Available at: https://www.wipo.int
- Korean Intellectual Property Office. Patent examination guidelines. (2021).
- USPTO. Patent examination procedures. (2022).
- European Patent Office. Patent best practices. (2022).
- Patent Office of China. Patent law and guidelines. (2020).
